Category Archives: ZeroHedge

Gold Miner Failures

January 20, 2024 By in DUST, GDX, GDXJ, Gold & Silver, Gold Miners, Inflation, JDST, ZeroHedge

One Failed Move, After Another

If it’s not working, get out or change sides.

For Junior Miners GDXJ, it’s the bullish case that’s not working.

But wait! What about ‘inflation’?

Here’s just one example of where the so-called ‘inflation’ is coming from: supply disruption and destruction.

Junior Gold Miners GDXJ, Weekly

As this post said, few things get more attention on The Street, than a failed move.

The chart shows at least three potential bullish set-ups that have failed.

Fail, fail, fail; what do we think GDXJ, will do at Monday’s open. Are we going higher?

Well, anything can happen; there’s a gap on the daily chart that could be filled. 

However, posting lower levels might be just getting started (not advice, not a recommendation).

Depending on Monday’s action we may have confirmation of a downside trend and channel.

More on that at the next update.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

Interest Rate Shakedown

January 16, 2024 By in Bonds, Federal Reserve, Interest Rates, TLT, ZeroHedge 2 Comments

The ‘Uh Oh’ Moment

Now it begins, sowing the seeds of doubt.

‘First rate cut may be later than expected.’

How about be prepared for no rate cuts this year and more likely, continued elevated rates or higher rates (not advice, not a recommendation).

Let’s not forget we’re over a year now from the release of this post, postulating there would be no ‘Fed pivot’.

So far, no pivot and no cut.

Now that nearly everyone’s positioned on the ‘rate cut’ side, it’s time for the shakedown, possibly beginning today.

Long Bonds TLT, Daily

Just over two-weeks ago, this post noted to be on the watch for a failed breakout.

Looking at the result, we’re now below the prior breakout resistance, a bearish sign.

The chart of bonds itself is telling us (unless it’s reversed to the upside), there’s an increased chance rates are more likely to move higher (not advice, not a recommendation).

Note the ‘persistence’ to the downside of the MACD indicator. This tends to happen when sustained pressure is being applied … selling pressure in this case.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

Gold’s Technical Exhaustion

January 6, 2024 By in DUST, Federal Reserve, GDX, GDXJ, GLD, Gold & Silver, Gold Miners, JDST, Richie Naso, Uneducated Economist, ZeroHedge

Divergences, What Happens Next?

Is gold about to blow up?

Blow-up breakout? … No, blow-up breakdown.

As we’ll see in the chart of GLD below, double bearish divergence on the daily.

At time stamp 6:10, here, in the Fed’s own words, rates are not coming down, they’re likely to go higher.

‘We will need to increase the Fed’s funds rates further …’

Not forgetting bonds, may have already reversed, here.

Then, liquidity crunch … yet to appear in full force.

Next, a reminder, herd instinct is strong, link here.

Gold GLD, Daily

On a daily basis, we have a double bearish MACD divergence coupled with a terminating wedge.

As veteran trader Richie Naso says, ‘It’s all about patterns‘.

Let’s add intrigue, here (time stamp 13:58), finding out what happens in a liquidity crisis, i.e., ‘Sell everything.’

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Going Short on ‘Corrective Waves’

November 18, 2023 By in $SPSIBI, Biotech, Gold & Silver, IYR, LABD, LABD-23-13, Positions, SLV, SPBIO, SRS, SRS-23-04, XBI, ZeroHedge, zsl, ZSL-23-01 2 Comments

All The Same ‘Look’

Did we just have the largest bull trap in market history?

Now, after the bulls (may) have been caught off-guard, we have this; the specter of ‘deflation‘ and demand destruction.

Last Tuesday’s CPI report provided a backdrop for the continued squeeze higher.

Over the past several weeks, at least three markets have developed the same (bearish) ‘look’.

They’re posting corrective ‘a-b-c’ price action, going against the main trend.

SLV, IYR & XBI, Weekly

Take a look, all similar in their formation.

Positioning

As of the close on Friday, I have positioned short in all three markets (not advice, not a recommendation).

The IYR short was initiated this past Wednesday, the Silver short on Thursday, then just minutes before the close on Friday, the biotech short.

Trades are labeled as SRS-23-04, ZSL-23-01, LABD-23-13

Next Steps

The coming week is likely to see one, or a variation of the following: all trades stopped out, one or two trades with discretionary exit, then followed by potential concentration on the best candidate.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Santa Clause Rally?

November 4, 2023 By in IYR, Positions, Real Estate, SRS, SRS-23-03, ZeroHedge 2 Comments

Here We Go, Again

In the markets, anything can happen.

There could be a sustainable rally into Christmas but is that the highest probability?

When looking at the chart of real estate IYR, the short answer is (most likely) no.

Strategy Review

Back in August, potential for the breakdown of a fourteen-year-long, trendline was identified.

Since then, we’ve had that break.

Then, this past week was a test of the breakdown.

As we’ll see in the chart below, from a trading standpoint, we’re at The Danger Point®

Price action closed the week hovering just below resistance in what looks like a sharp short-covering rally.

Real Estate IYR, Daily

As shown, a short position was opened via Leveraged Inverse Fund SRS, as price action was backing away from the blue-line resistance area (not advice, not a recommendation).

We’ll find out at the next open, if going short was a good idea or not. 🙂

The important part is, we’re at resistance.

If IYR, is to continue to rally, it would probably need to spend time at that resistance absorbing all the sellers.

If so, that gives the speculator a hint, higher prices are ahead and to exit the trade (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

‘Free-Fall’, For Biotech … Closer

October 12, 2023 By in $SPSIBI, Biotech, LABD-23-10, LABD-23-11, Positions, SPBIO, The List, ZeroHedge 2 Comments

Downside Pressure Builds

With this session’s price action continuing lower, getting back into the short trade (via LABD) was the correct move (not advice, not a recommendation).

With that said, we’re nearing the dangerous part.

Downside pressure continues to build.

As the chart shows, SPBIO ($SPSIBI) is close to the point where there’s no more support until much lower levels.

Biotech SPBIO ($SPSIBI), Daily

The Blue arrows highlight short entries (via LABD).

Short No. 1 was subsequently stopped out yesterday, then re-established (the same day) at the next arrow, No. 2.

If and when price action gets to the ‘free-fall’ area, anything can happen.

We could bounce off the support level, hover at it, or slice straight through.

Positioning

It’s obvious this sector’s in trouble. The fundamentals continue to build.

Just a few days after this post we have two more to add to ‘The List’, here and here.

Yesterday’s post showed a not-so-good entry that at this point in today’s session, has been ‘healed’ by price action.

We’re well above that (LABD 21.69) entry and solidly in the green (not advice, not a recommendation).

The stop on the LABD-23-11, position is now being moved (tentatively) higher at today’s low of, LABD 22.01.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech (Short) Trade Update

October 9, 2023 By in $SPSIBI, Biotech, LABD, LABD-23-10, Positions, SPBIO, The List, ZeroHedge 2 Comments

Behind The Scenes, Biotech Verifies Trend

Hardly a day goes by where we don’t get some kind of biotech ‘conspiracy’ or exposé like this, this, this, or this.

True or not, from a trading standpoint, we’re interested in reality.

So far, that reality, i.e., the price action, says that out of all the major sectors (except bonds, perhaps), biotech, and specifically, SPBIO ($SPSIBI) is the weakest (not advice, not a recommendation).

The Trade With No Name

Since the existing short on biotech via LABD is solidly in the green (original entry @ 16.99), it’s going to be tracked on this site as LABD-23-10, indicating the tenth series (trade campaign) this year.

Biotech SPBIO, 3X Leveraged Inverse LABD, Daily

The first chart shows the original entry (documented here and here) and the stop progression.

The second chart shows that we’re in a trading channel, confirmed with today’s higher (daily) high, with SPBIO, lower.

During this session, the stop has been tightened up to LABD 20.74 (Friday’s low).

With that, it could all be over soon, i.e., getting stopped out; or, it’s just a continuing series of well-disciplined progressions protecting open profit (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

When Costco Sells Gold

October 1, 2023 By in China, Food Supply, Genesis 41, GLD, GOLD, Gold & Silver, Gold Miners, serpentza, The List, The Speck, Wyckoff, ZeroHedge

The Mother of All Contrary Indicators

This has to be it, right?

Selling gold in a supermarket; an expensive commodity, peddled to the least informed and least capitalized segment of the public.

Once that market’s saturated, who’s left?

Going Down Memory Lane

It’s been nearly three years since this post.

From a long-term strategy standpoint, this site has been consistent; it’s the food supply first, then gold and silver (not advice, not a recommendation).

The next shoe has yet to drop on how or what’s going to be used to extract (or confiscate) precious metals from the (stacking) proletariat.

With craziness by the day, anything can happen.

Gold: Turning Points & Technical

So far, it’s been three-for-three (here, here and here) identifying recent significant technical conditions and turning points for gold, GLD.

At this juncture, the dollar collapse, and the silver/gold bull launch are just not happening. It’s not there … something else is going on (not advice, not a recommendation).

We’re in the middle of a massive sovereign bankruptcy (Time Stamp 7:10) that’s never happened before.

What’s going on behind the scenes is not visible to us.

However, from a Wyckoff analysis standpoint, those (hidden) actions and decisions show up on the chart(s).

Contrary Indicator

Remember Baghdad Bob?

Constantly giving press conferences discussing the strength of the military campaign when the exact opposite was true.

It may be so with gold as well (not advice, not a recommendation).

The local supermarket has decided, after a 22-year long bull market, it’s ‘safe’ for profit.

The hapless public is now standing at the gold kiosk; with face-mask firmly secured, arm bandaged from the latest booster, EV FOB in hand (or pocket), hypnotized into yet another mania.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech Sector, Buckles

September 28, 2023 By in $SPSIBI, Biotech, LABD, Positions, SPBIO, Speck-Effect, The List, The Speck, ZeroHedge 1 Comment

Bad, And More Bad News

It’s been a little nerve-wracking over the past two sessions being short biotech; was it an upward correction, or a full-blown reversal?

No one really knows, until it’s over.

Well, as of today’s new daily low in index SPBIO, it looks like what is now seen as a correction, may be complete (not advice, not a recommendation).

Bad, And More Bad

On the fundamental side, The List keeps building with links like this, this and this.

However, keep in mind, it may be something as simple as rising interest rates that’s ultimately going to collapse biotech and the rest of the markets (not advice, not a recommendation).

Moving on and looking at the chart of SPBIO, there’s a trend confirmation and potential trading channel.

Biotech SPBIO, Daily

The left side line is the trend … the right-side line is what’s called the ‘reverse trendline’ and possibly defines the trading channel.

As of this post (12:30 p.m., EST) the SPBIO, is doing all it can to reverse higher, against what may be the over-riding (down) trend.

So far, the daily high of SPBIO 5764.73, remains intact.

Positioning

As a result of today’s new SPBIO low, the stop has been moved on the position in the inverse fund LABD, from LABD 18.22, to LABD 19.18 (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

The ‘Event Horizon’

September 16, 2023 By in $SPSIBI, CBDC, Daniela Cambone, Edward Dutton, Excess Deaths, LABD, Positions, SPBIO, Wyckoff, ZeroHedge 3 Comments

Set In Motion

Serious students of the markets discover quickly enough, price action has nothing to do with forecasts or fundamentals.

Once that mental hurdle is overcome, the market landscape takes on a whole new meaning.

Moving Parts, A-Plenty

At present, there’re a lot of moving parts but a few things are known: the on-going population collapse, the soon-to-be market and currency collapse (or severe de-basement), the possible ‘balkanization‘ of the U.S., just for starters.

Those wheels have already been set in motion.

Within that construct, are the market navigations (trading actions) presented on this site.

Biotech Has Spoken

At least for now, the bears are in control (not advice, not a recommendation).

The minor ‘spring’ set-up, materialized during Thursday’s session, just as this update said was likely.

It’s what happened next, that’s important.

On Friday, the set-up failed; showing the higher probability is for more downside.

Biotech SPBIO, Daily

Price action is posting lower.

The potential trading channel has been re-drawn with the grey lines; indicating the possibility for more aggressive downside action (not advice, not a recommendation).

Positioning

As can be inferred with these updates, I’ve already positioned short this sector via leveraged inverse fund LABD (not advice, not a recommendation).

The stop is Thursday’s high (SPBIO, 6,135.81) which corresponds to LABD 16.66 (interesting, that).

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279